Home / Recalls / BayCare Integrated Service Center, LLC /Dba BayCare Central Pharmacy / D-0702-2021

D-0702-2021 Class II Terminated

Recalled by BayCare Integrated Service Center, LLC /Dba BayCare Central Pharmacy — Temple Terrace, FL

FDA drug recall D-0702-2021 was initiated by BayCare Integrated Service Center, LLC /Dba BayCare Central Pharmacy on Jul 30, 2021 and is designated Class II. Reason for recall: Lack of sterility assurance The recall status is terminated (terminated Oct 22, 2021). Affected quantity: 253 syringes.

Recall details

Product Type: Drugs
Report Date: Aug 11, 2021
Initiation Date: Jul 30, 2021
Termination Date: Oct 22, 2021
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 253 syringes

Product description

Succinylcholine Chloride 100 mg/5 mL (20 mg/mL), 5 mL Syringes, Rx only, For IV Use only, BayCare Central Pharmacy, 7802 E. Telecom Parkway, Temple Terrace, FL 33837

Reason for recall

Lack of sterility assurance

Distribution pattern

Code information

Lot: SUCC10020210624 Exp. 09/22/2021

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0702-2021
openFDA file date: Nov 10, 2026
Loaded by RegDataLab: Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.